Allergan receives FDA approval of Juvéderm VOLUMA XC for mid-face injection

Allergan receives FDA approval of Juvéderm VOLUMA XC for mid-face injection

Source: 
Pharmaceutical Business Review
snippet: 


Allergan has received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula for cheek augmentation to correct age-related volume deficit in the mid-face in adults over 21.